e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity
Rietema H., Holverda S., Bogaard H. J., Marcus J. T., Smit H. J., Westerhof N., Postmus P. E., Boonstra A., Vonk-Noordegraaf A.
Source:
Eur Respir J 2008; 31: 759-764
Journal Issue:
April
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rietema H., Holverda S., Bogaard H. J., Marcus J. T., Smit H. J., Westerhof N., Postmus P. E., Boonstra A., Vonk-Noordegraaf A.. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J 2008; 31: 759-764
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study
Source: Eur Respir J 2012; 40: 298-305
Year: 2012
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Effects of pulmonary rehabilitation on operational chest wall volumes during exercise in COPD patients
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Effects of rehabilitation on chest wall volume regulation during exercise in COPD patients
Source: Eur Respir J 2007; 29: 284-291
Year: 2007
Echocardiographic measurements in hypoxemic COPD patients receiving long-term oxygen therapy
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Pulmonary hypertension in COPD: results from the ASPIRE registry
Source: Eur Respir J 2013; 41: 1292-1301
Year: 2013
Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
Right ventricular interaction in pulmonary arterial hypertension
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008
Stroke volume response and exercise capacity in COPD with and without pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 641s
Year: 2006
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
A therapeutic arteriovenous fistula not only improves exercise tolerance, but also BODE index in patients with severe COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
COPD and CHF
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Long-term effects of bosentan on the heart and pulmonary hemodynamics in pulmonary arterial hypertension, a comparison study with epoprostenol
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 137-142
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept